Ian James Amanna

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$5.5MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20182020
AwardsPatents
Federal awards as principal investigator

6 awards · $5.5M

DateAgencyAwardAmountCompany
Jan 23, 2020NIHSBIR Phase II
Development of a Yellow Fever Vaccine for a Vulnerable Population
$997KNAJIT TECHNOLOGIES, INC.
Aug 1, 2019NIHSBIR Phase I
Optimization of vaccine antigen for the development of improved influenza
$224KNAJIT TECHNOLOGIES, INC.
Feb 7, 2019NIHSBIR Phase II
Development of an H2O2-inactivated chikungunya virus vaccine
$989KNAJIT TECHNOLOGIES, INC.
Jan 16, 2019NIHSBIR Phase II
Development of a Yellow Fever Vaccine for a Vulnerable Population
$997KNAJIT TECHNOLOGIES, INC.
Feb 16, 2018NIHSBIR Phase II
Development of an H2O2-inactivated chikungunya virus vaccine
$995KNAJIT TECHNOLOGIES, INC.
Jan 25, 2018NIHSBIR Phase II
Development of a Yellow Fever Vaccine for a Vulnerable Population
$1.2MNAJIT TECHNOLOGIES, INC.
Among 4,078 researchers in Biotech

Peer ranks

Federal funding#234
Awards as PI#315
Patents#273
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.